AAAAAA

   
Results: 1-19 |
Results: 19
EPITOPE MAPPING OF HUMAN CYP1A2 IN DIHYDRALAZINE-INDUCED AUTOIMMUNE HEPATITIS
Authors: BELLOC C GAUFFRE A ANDRE C BEAUNE PH
Citation: C. Belloc et al., EPITOPE MAPPING OF HUMAN CYP1A2 IN DIHYDRALAZINE-INDUCED AUTOIMMUNE HEPATITIS, Pharmacogenetics, 7(3), 1997, pp. 181-186
AUTOANTIBODIES AGAINST A KIDNEY - LIVER PROTEIN ASSOCIATED WITH QUINOLONE-INDUCED ACUTE INTERSTITIAL NEPHRITIS OR HEPATITIS
Authors: GAUFFRE A MIRCHEVA J GLOTZ D FILLASTRE JP SIMON P BEAUNE PH DRUET P
Citation: A. Gauffre et al., AUTOANTIBODIES AGAINST A KIDNEY - LIVER PROTEIN ASSOCIATED WITH QUINOLONE-INDUCED ACUTE INTERSTITIAL NEPHRITIS OR HEPATITIS, Nephrology, dialysis, transplantation, 12(9), 1997, pp. 1961-1962
IMMUNOTOXICOLOGY OF THE LIVER - ADVERSE REACTIONS TO DRUGS
Authors: BEAUNE PH LECOEUR S
Citation: Ph. Beaune et S. Lecoeur, IMMUNOTOXICOLOGY OF THE LIVER - ADVERSE REACTIONS TO DRUGS, Journal of hepatology, 26, 1997, pp. 37-42
THE USE OF HUMAN IN-VITRO METABOLIC PARAMETERS TO EXPLORE THE RISK ASSESSMENT OF HAZARDOUS COMPOUNDS - THE CASE OF ETHYLENE DIBROMIDE
Authors: PLOEMEN JPHTM WORMHOUDT LW HAENEN GRMM OUDSHOORN MJ COMMANDEUR JNM VERMEULEN NPE DEWAZIERS I BEAUNE PH WATABE T VANBLADEREN PJ
Citation: Jphtm. Ploemen et al., THE USE OF HUMAN IN-VITRO METABOLIC PARAMETERS TO EXPLORE THE RISK ASSESSMENT OF HAZARDOUS COMPOUNDS - THE CASE OF ETHYLENE DIBROMIDE, Toxicology and applied pharmacology, 143(1), 1997, pp. 56-69
CYP3A5 IS THE MAJOR CYTOCHROME-P450 3A EXPRESSED IN HUMAN COLON AND COLONIC CELL-LINES
Authors: GERVOT L CARRIERE V COSTET P CUGNENC PH BERGER A BEAUNE PH DEWAZIERS I
Citation: L. Gervot et al., CYP3A5 IS THE MAJOR CYTOCHROME-P450 3A EXPRESSED IN HUMAN COLON AND COLONIC CELL-LINES, Environmental toxicology and pharmacology, 2(4), 1996, pp. 381-388
ANTI-CYTOCHROME P450 AUTOANTIBODIES IN DRUG-INDUCED DISEASE
Authors: BEAUNE PH LECOEUR S BOURDI M GAUFFRE A BELLOC C DANSETTE P MANSUY D
Citation: Ph. Beaune et al., ANTI-CYTOCHROME P450 AUTOANTIBODIES IN DRUG-INDUCED DISEASE, European journal of haematology, 57, 1996, pp. 89-92
HUMAN CYTOCHROMES P450 EXPRESSED IN ESCHERICHIA-COLI - PRODUCTION OF SPECIFIC ANTIBODIES
Authors: BELLOC C BAIRD S COSME J LECOEUR S GAUTIER JC CHALLINE D DEWAZIERS I FLINOIS JP BEAUNE PH
Citation: C. Belloc et al., HUMAN CYTOCHROMES P450 EXPRESSED IN ESCHERICHIA-COLI - PRODUCTION OF SPECIFIC ANTIBODIES, Toxicology, 106(1-3), 1996, pp. 207-219
TIENILIC ACID-INDUCED AUTOIMMUNE HEPATITIS - ANTI-LIVER AND ANTI-KIDNEY MICROSOMAL TYPE-2 AUTOANTIBODIES RECOGNIZE A 3-SITE CONFORMATIONAL EPITOPE ON CYTOCHROME-P4502C9
Authors: LECOEUR S ANDRE C BEAUNE PH
Citation: S. Lecoeur et al., TIENILIC ACID-INDUCED AUTOIMMUNE HEPATITIS - ANTI-LIVER AND ANTI-KIDNEY MICROSOMAL TYPE-2 AUTOANTIBODIES RECOGNIZE A 3-SITE CONFORMATIONAL EPITOPE ON CYTOCHROME-P4502C9, Molecular pharmacology, 50(2), 1996, pp. 326-333
INTERINDIVIDUAL VARIABILITY IN THE OXIDATION OF 1,2-DIBROMOETHANE - USE OF HETEROLOGOUSLY EXPRESSED HUMAN CYTOCHROME-P450 AND HUMAN LIVER-MICROSOMES
Authors: WORMHOUDT LW PLOEMEN JHTM DEWAZIERS I COMMANDEUR JNM BEAUNE PH VANBLADEREN PJ VERMEULEN NPE
Citation: Lw. Wormhoudt et al., INTERINDIVIDUAL VARIABILITY IN THE OXIDATION OF 1,2-DIBROMOETHANE - USE OF HETEROLOGOUSLY EXPRESSED HUMAN CYTOCHROME-P450 AND HUMAN LIVER-MICROSOMES, Chemico-biological interactions, 101(3), 1996, pp. 175-192
INSULIN DOWN-REGULATES CYTOCHROME-P450 2B AND 2E EXPRESSION AT THE POSTTRANSCRIPTIONAL LEVEL IN THE RAT HEPATOMA-CELL LINE
Authors: DEWAZIERS I GARLATTI M BOUGUET J BEAUNE PH BAROUKI R
Citation: I. Dewaziers et al., INSULIN DOWN-REGULATES CYTOCHROME-P450 2B AND 2E EXPRESSION AT THE POSTTRANSCRIPTIONAL LEVEL IN THE RAT HEPATOMA-CELL LINE, Molecular pharmacology, 47(3), 1995, pp. 474-479
SPECIFICITY OF IN-VITRO COVALENT BINDING OF TIENILIC ACID METABOLITESTO HUMAN LIVER-MICROSOMES IN RELATIONSHIP TO THE TYPE OF HEPATOTOXICITY - COMPARISON WITH 2 DIRECTLY HEPATOTOXIC DRUGS
Authors: LECOEUR S BONIERBALE E CHALLINE D GAUTIER JC VALADON P DANSETTE PM CATINOT R BALLET F MANSUY D BEAUNE PH
Citation: S. Lecoeur et al., SPECIFICITY OF IN-VITRO COVALENT BINDING OF TIENILIC ACID METABOLITESTO HUMAN LIVER-MICROSOMES IN RELATIONSHIP TO THE TYPE OF HEPATOTOXICITY - COMPARISON WITH 2 DIRECTLY HEPATOTOXIC DRUGS, Chemical research in toxicology, 7(3), 1994, pp. 434-442
REGULATION OF CYTOCHROME-P450 EXPRESSION BY INSULIN
Authors: DEWAZIERS I GARLATTI M BOUQUET J BEAUNE PH BAROUKI R
Citation: I. Dewaziers et al., REGULATION OF CYTOCHROME-P450 EXPRESSION BY INSULIN, The FASEB journal, 8(7), 1994, pp. 10001251-10001251
CYTOCHROME-P-450 FOLLOWS A MICROTUBULE-DEPENDENT VESICULAR ROUTE TO THE PLASMA-MEMBRANE
Authors: ROBIN MA MARATRAT M LOEPER J DURANDSCHNEIDER AM TINEL M BALLET F BEAUNE PH FELDMANN G PESSAYRE D
Citation: Ma. Robin et al., CYTOCHROME-P-450 FOLLOWS A MICROTUBULE-DEPENDENT VESICULAR ROUTE TO THE PLASMA-MEMBRANE, Hepatology, 19(4), 1994, pp. 90000118-90000118
HUMAN RECOMBINANT INTERLEUKIN-2 (RHIL-2) DECREASES THE EXPRESSION OF CYTOCHROMES-P-450 (P-450) IN CULTURED RAT HEPATOCYTES
Authors: TINEL M ROBIN MA DOOSTZADEH J ELKAHWAJI J BEAUNE PH PESSAYRE D
Citation: M. Tinel et al., HUMAN RECOMBINANT INTERLEUKIN-2 (RHIL-2) DECREASES THE EXPRESSION OF CYTOCHROMES-P-450 (P-450) IN CULTURED RAT HEPATOCYTES, Hepatology, 19(4), 1994, pp. 90000132-90000132
INTERACTIONS OF DIHYDRALAZINE WITH CYTOCHROMES-P4501A - A POSSIBLE EXPLANATION FOR THE APPEARANCE OF ANTI-CYTOCHROME-P4501A2 AUTOANTIBODIES
Authors: BOURDI M TINEL M BEAUNE PH PESSAYRE D
Citation: M. Bourdi et al., INTERACTIONS OF DIHYDRALAZINE WITH CYTOCHROMES-P4501A - A POSSIBLE EXPLANATION FOR THE APPEARANCE OF ANTI-CYTOCHROME-P4501A2 AUTOANTIBODIES, Molecular pharmacology, 45(6), 1994, pp. 1287-1295
EXPRESSION OF CYTOCHROME-P450 IN RAT PLEURAL MESOTHELIAL CELLS IN SECONDARY CULTURES
Authors: BUARD A BEAUNE PH RENIER A JAURAND MC BIGNON J LAURENT P
Citation: A. Buard et al., EXPRESSION OF CYTOCHROME-P450 IN RAT PLEURAL MESOTHELIAL CELLS IN SECONDARY CULTURES, Journal of cellular physiology, 160(1), 1994, pp. 176-184
IDENTIFICATION OF THE MAJOR HUMAN HEPATIC CYTOCHROME-P450 INVOLVED INACTIVATION AND N-DECHLOROETHYLATION OF IFOSFAMIDE
Authors: WALKER D FLINOIS JP MONKMAN SC BELOC C BODDY AV CHOLERTON S DALY AK LIND MJ PEARSON ADJ BEAUNE PH IDLE JR
Citation: D. Walker et al., IDENTIFICATION OF THE MAJOR HUMAN HEPATIC CYTOCHROME-P450 INVOLVED INACTIVATION AND N-DECHLOROETHYLATION OF IFOSFAMIDE, Biochemical pharmacology, 47(7), 1994, pp. 1157-1163
PRINCIPAL XENOBIOTIC-METABOLIZING ENZYME-SYSTEMS IN HUMAN HEAD AND NECK SQUAMOUS-CELL CARCINOMA
Authors: JANOT F MASSAAD L RIBRAG V DEWAZIERS I BEAUNE PH LUBOINSKI B PARISE O GOUYETTE A CHABOT GG
Citation: F. Janot et al., PRINCIPAL XENOBIOTIC-METABOLIZING ENZYME-SYSTEMS IN HUMAN HEAD AND NECK SQUAMOUS-CELL CARCINOMA, Carcinogenesis, 14(7), 1993, pp. 1279-1283
SCREENING OF MAIN DRUG-METABOLIZING-ENZYMES IN MOUSE AND HUMAN COLON TUMORS
Authors: MASSAAD L DEWAZIERS I RIBRAG V JANOT F MORIZET J BEAUNE PH GOUYETTE A CHABOT GG
Citation: L. Massaad et al., SCREENING OF MAIN DRUG-METABOLIZING-ENZYMES IN MOUSE AND HUMAN COLON TUMORS, Bulletin du cancer, 80(5), 1993, pp. 397-407
Risultati: 1-19 |